Reduced healthcare utilization following successful hepatitis C virus treatment in HIV‐co‐infected patients with mild liver disease

New direct‐acting antivirals (DAA) for hepatitis C virus (HCV) infection have achieved high cure rates in many patient groups previously considered difficult‐to‐treat, including those HIV/HCV co‐infected. The high price of these medications is likely to limit access to treatment, at least in the sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Padam, P., Clark, S., Irving, W., Gellissen, R., Thomson, E., Main, J., Cooke, G. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924594/
https://www.ncbi.nlm.nih.gov/pubmed/26511293
http://dx.doi.org/10.1111/jvh.12484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924594/
https://www.ncbi.nlm.nih.gov/pubmed/26511293
http://dx.doi.org/10.1111/jvh.12484

Ejemplares similares